Ian Landi

449 total citations
2 papers, 33 citations indexed

About

Ian Landi is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Ian Landi has authored 2 papers receiving a total of 33 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Molecular Biology, 1 paper in Oncology and 1 paper in Immunology and Allergy. Recurrent topics in Ian Landi's work include Peptidase Inhibition and Analysis (1 paper), Cell Adhesion Molecules Research (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). Ian Landi is often cited by papers focused on Peptidase Inhibition and Analysis (1 paper), Cell Adhesion Molecules Research (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). Ian Landi collaborates with scholars based in United States. Ian Landi's co-authors include John E. Phay, Prashant Trikha, Ching‐Shih Chen, Vinicio Carloni, Andrew Stiff, Michael A. Caligiuri, Shalini Gautam, Susheela Tridandapani, Robert Wesolowski and Xiaokui Mo and has published in prestigious journals such as Journal of Hepatology and OncoImmunology.

In The Last Decade

Ian Landi

2 papers receiving 33 citations

Peers

Countries citing papers authored by Ian Landi

Since Specialization

Citations

This map shows the geographic impact of Ian Landi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Landi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Landi more than expected).

Fields of papers citing papers by Ian Landi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Landi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Landi. The network helps show where Ian Landi may publish in the future.

Co-authorship network of co-authors of Ian Landi

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Landi. A scholar is included among the top collaborators of Ian Landi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Landi. Ian Landi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

#	Work	Indexed citations
1	Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator 2016 ·OncoImmunology ·Prashant Trikha, (unknown), Andrew Stiff, Shalini Gautam, (unknown), (unknown), Robert Wesolowski, Ian Landi, Xiaokui Mo, John E. Phay, Ching‐Shih Chen, John C. Byrd, Michael A. Caligiuri, Susheela Tridandapani, William E. Carson	26
2	The alpha6 beta1 integrin is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of hepatocarcinoma cells 2001 ·Journal of Hepatology ·Ian Landi, Antonio Mazzocca, Vinicio Carloni	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact